Causes of death in HIV-infected patients from the Cologne-Bonn cohort

被引:29
|
作者
Ehren, K. [1 ]
Hertenstein, C. [1 ]
Kuemmerle, T. [1 ]
Vehreschild, J. J. [1 ,2 ]
Fischer, J. [1 ,2 ]
Gillor, D. [1 ]
Wyen, C. [1 ]
Lehmann, C. [1 ]
Cornely, O. A. [1 ,2 ,3 ]
Jung, N. [1 ]
Gravemann, S. [1 ,2 ]
Platten, M. [1 ,2 ]
Wasmuth, J. C. [4 ]
Rockstroh, J. K. [2 ,4 ]
Boesecke, C. [4 ]
Schwarze-Zander, C. [4 ]
Faetkenheuer, G. [1 ,2 ]
机构
[1] Univ Hosp Cologne, Dept Internal Med 1, D-50937 Cologne, Germany
[2] German Ctr Infect Res DZIF, Braunschweig, Germany
[3] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Clin Trials Ctr Cologne, ZKS Koln,BMBF 01KN1106, D-50931 Cologne, Germany
[4] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany
关键词
HIV; AIDS; Causes of death; Antiretroviral therapy; Mortality; HUMAN-IMMUNODEFICIENCY-VIRUS; LIVER-RELATED MORTALITY; ALL-CAUSE MORTALITY; ANTIRETROVIRAL THERAPY; CANCER; ADULTS; INDIVIDUALS; SMOKING; RISK; AIDS;
D O I
10.1007/s15010-013-0535-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Causes of death in human immunodeficiency virus (HIV)-infected subjects have changed in countries with high resources over the last several years. Acquired immunodeficiency syndrome (AIDS)-related diseases have become less prevalent, whereas deaths due to non-AIDS causes are increasing. The aim of the present study was to analyse causes of death in the Cologne-Bonn cohort. Causes of death from the Cologne-Bonn cohort between 2004 and 2010 were systematically recorded using the CoDe algorithm (The Coding Causes of Death in HIV Project). In 3,165 patients followed from 2004 to 2010, 182 deaths occurred (5.7 %, 153 males, 29 females). The median age at the time of death was 47 years (range 24-85 years). The most frequent causes of death were AIDS-defining events (n = 60, 33 %), with non-Hodgkin lymphoma (NHL) (n = 29, 16 %) and infections (n = 20, 11 %) being the leading entities in this category. Non-AIDS malignancies accounted for 16 % (n = 29), non-HIV-related infections for 10 % (n = 18), cardiovascular diseases for 7 % (n = 14), suicide or accident for 4 % (n = 7) and liver diseases for 3 % (n = 5) of deaths (unknown n = 47, 26 %). Although the majority of patients (92.5 %) was on antiretroviral therapy (ART), only 50 % were virologically suppressed (HIV-RNA < 50 copies/mL) and 44 % had a decreased CD4+ count (< 200/mu L) at their last visit before death. One-third of the causes of death in our cohort between 2004 and 2010 was AIDS-related. Since most of these deaths occur with severe immune suppression, they can possibly be prevented by the early diagnosis and treatment of HIV infection. Care providers must be aware of an increased risk for a broad range of diseases in HIV-infected patients and should apply appropriate preventive measures.
引用
收藏
页码:135 / 140
页数:6
相关论文
共 50 条
  • [21] Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000
    Morlat, Philippe
    Roussillon, Caroline
    Henard, Sandrine
    Salmon, Dominique
    Bonnet, Fabrice
    Cacoub, Patrice
    Georget, Aurore
    Aouba, Albertine
    Rosenthal, Eric
    May, Thierry
    Chauveau, Marie
    Diallo, Bilghissa
    Costagliola, Dominique
    Chene, Genevieve
    AIDS, 2014, 28 (08) : 1181 - 1191
  • [22] Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997
    Vandentorren, S
    Mercié, P
    Marimoutou, C
    Neau, D
    Malvy, D
    Farbos, S
    Dabis, F
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (01) : 7 - 10
  • [23] Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort
    Tien, Phyllis C.
    Choi, Andy I.
    Zolopa, Andrew R.
    Benson, Constance
    Tracy, Russell
    Scherzer, Rebecca
    Bacchetti, Peter
    Shlipak, Michael
    Grunfeld, Carl
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (03) : 316 - 322
  • [24] ANTIRETROVIRAL THERAPY AND ARTERIAL ELASTICITY IN HIV-INFECTED PATIENTS
    Kundro, Mariana A.
    Viloria, Guillermo A.
    Toibaro, Javier J.
    Losso, Marcelo H.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 365 - 369
  • [25] Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible From the STOPSHIV Project Cohort
    De Socio, Giuseppe Vittorio
    Ricci, Elena
    Maggi, Paolo
    Orofino, Giancarlo
    Squillace, Nicola
    Menzaghi, Barbara
    Madeddu, Giordano
    Di Biagio, Antonio
    Francisci, Daniela
    Bonfanti, Paolo
    Vichi, Francesca
    dell'Omo, Marco
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 83 (05) : 496 - 503
  • [26] Influenza vaccination in HIV-infected patients
    Jedrychowski, Michal
    Czepiel, Jacek
    Michalak, Mateusz
    Garlicki, Aleksander
    HIV & AIDS REVIEW, 2019, 18 (01): : 44 - 49
  • [27] Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011
    Yanik, Elizabeth L.
    Tamburro, Kristen
    Eron, Joseph J.
    Damania, Blossom
    Napravnik, Sonia
    Dittmer, Dirk P.
    INFECTIOUS AGENTS AND CANCER, 2013, 8
  • [28] Hepatitis B in HIV-Infected Patients
    Soriano, Vincent
    Poveda, Eva
    Vispo, Eugenia
    Barreiro, Pablo
    CLINICS IN LIVER DISEASE, 2013, 17 (03) : 489 - +
  • [29] Cerebrovascular Diseases in HIV-Infected Patients
    Monsuez, Jean-Jacques
    Goujon, Colette
    Wyplosz, Benjamin
    Couzigou, Carine
    Escaut, Lelia
    Vittecoq, Daniel
    CURRENT HIV RESEARCH, 2009, 7 (05) : 475 - 480
  • [30] Factors associated with deaths from suicide in a French nationwide HIV-infected cohort
    Hentzien, M.
    Cabie, A.
    Pugliese, P.
    Billaud, E.
    Poizot-Martin, I.
    Duvivier, C.
    Valantin, M-A
    Kaladjian, A.
    Drame, M.
    Bani-Sadr, F.
    HIV MEDICINE, 2018, 19 (08) : 551 - 558